Correction to: Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner (Nature Medicine, (2011), 17, 8, (961-967), 10.1038/nm.2378);Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner

Nature Medicine

Volumn 17, Issue 8, 2011, Pages 961-967

  Pajvani, Utpal B ^a   Shawber, Carrie J ^a   Samuel, Varman T ^b   Birkenfeld, Andreas L ^b   Shulman, Gerald I ^b   Kitajewski, Jan ^a   Accili, Domenico ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE INHIBITOR; GLUCOSE 6 PHOSPHATASE; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR FKHR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIET; DIET RESTRICTION; GENE LOSS; GENE MUTATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HAPLOINSUFFICIENCY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALIA; MUS;

EID: 79961173038     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/s41591-023-02695-9     Document Type: Erratum

References (46)

1. Accili, D. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53, 1633-1642 (2004). (Pubitemid 38857019)
2. Kahn, S.E. et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355, 2427-2443 (2006). (Pubitemid 44903747)
3. Kim-Muller, J.Y. & Accili, D. Cell biology. Selective insulin sensitizers. Science 331, 1529-1531 (2011).
4. Haeusler, R.A., Kaestner, K.H. & Accili, D. FoxOs function synergistically to promote hepatic glucose production. J. Biol. Chem. 285, 35245-35248 (2010).
5. Nakae, J. et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32, 245-253 (2002).
6. Nakae, J., Park, B.C. & Accili, D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem. 274, 15982-15985 (1999).
7. Altomonte, J. et al. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 285, E718-E728 (2003). (Pubitemid 37176422)
8. Matsumoto, M., Pocai, A., Rossetti, L., Depinho, R.A. & Accili, D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6, 208-216 (2007). (Pubitemid 47336849)
9. Fortini, M.E. Notch signaling: the core pathway and its posttranslational regulation. Dev. Cell 16, 633-647 (2009).
10. Dufraine, J., Funahashi, Y. & Kitajewski, J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 27, 5132-5137 (2008).
11. Weinmaster, G. & Kopan, R. A garden of Notch-ly delights. Development 133, 3277-3282 (2006). (Pubitemid 44501830)
12. Zong, Y. et al. Notch signaling controls liver development by regulating biliary differentiation. Development 136, 1727-1739 (2009).
13. Loomes, K.M. et al. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage. Hepatology 45, 323-330 (2007). (Pubitemid 46374589)
14. Xue, Y. et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8, 723-730 (1999). (Pubitemid 29189039)
15. Oka, C. et al. Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 121, 3291-3301 (1995).
16. Kitamura, T. et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J. Clin. Invest. 117, 2477-2485 (2007). (Pubitemid 47494349)
17. Postic, C. & Magnuson, M.A. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26, 149-150 (2000). (Pubitemid 30158104)
18. Das, I. et al. Notch oncoproteins depend on γ-secretase/presenilin activity for processing and function. J. Biol. Chem. 279, 30771-30780 (2004). (Pubitemid 38938010)
19. Nakae, J., Kitamura, T., Silver, D.L. & Accili, D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-1367 (2001). (Pubitemid 33107764)
20. Wang, J. et al. Effects of adenovirus-mediated liver-selective overexpression of protein tyrosine phosphatase-1b on insulin sensitivity in vivo. Diabetes Obes. Metab. 3, 367-380 (2001). (Pubitemid 33072217)
21. Rand, M.D. et al. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol. Cell. Biol. 20, 1825-1835 (2000). (Pubitemid 30100199)
22. Wolfe, M.S. γ-Secretase in biology and medicine. Semin. Cell Dev. Biol. 20, 219-224 (2009).
23. van Es, J.H. et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435, 959-963 (2005). (Pubitemid 40896322)
24. Milano, J. et al. Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. 82, 341-358 (2004). (Pubitemid 39485346)
25. Samuel, V.T. et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55, 2042-2050 (2006). (Pubitemid 44509978)
26. Accili, D. & Arden, K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117, 421-426 (2004). (Pubitemid 38610228)
27. Huang, A. et al. Functional silencing of hepatic microsomal glucose-6-phosphatase gene expression in vivo by adenovirus-mediated delivery of short hairpin RNA. FEBS Lett. 558, 69-73 (2004). (Pubitemid 38167412)
28. Chopra, A.R. et al. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322, 1395-1399 (2008). (Pubitemid 352775254)
29. Horton, J.D., Goldstein, J.L. & Brown, M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002). (Pubitemid 34496588)
30. Kim, J.J. et al. FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue. Diabetes 58, 1275-1282 (2009).
31. Nakae, J. et al. Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes 57, 563-576 (2008).
32. Nakae, J. et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4, 119-129 (2003). (Pubitemid 36105338)
33. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. & Scherer, P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953 (2001). (Pubitemid 32756433)
34. Pajvani, U.B. et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073-9085 (2003). (Pubitemid 36800387)
35. Woo, H.N., Park, J.S., Gwon, A.R., Arumugam, T.V. & Jo, D.G. Alzheimer's disease and Notch signaling. Biochem. Biophys. Res. Commun. 390, 1093-1097 (2009).
36. Purow, B. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr. Pharm. Biotechnol. 10, 154-160 (2009).
37. Moellering, R.E. et al. Direct inhibition of the NOTCH transcription factor complex. Nature 462, 182-188 (2009).
38. Fujikura, J. et al. Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas. Cell Metab. 3, 59-65 (2006).
39. Paik, J.H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323 (2007).
40. Hosaka, T. et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 101, 2975-2980 (2004). (Pubitemid 38327721)
41. Krebs, L.T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343-1352 (2000). (Pubitemid 30397078)
42. Plum, L. et al. The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat. Med. 15, 1195-1201 (2009).
43. Lin, H.V. et al. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 59, 337-346 (2010).
44. Collins, Q.F. et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J. Biol. Chem. 282, 30143-30149 (2007). (Pubitemid 350035266)
45. Schmoll, D. et al. Regulation of glucose-6-phosphatase gene expression by protein kinase Bα and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and-independent effects of insulin on promoter activity. J. Biol. Chem. 275, 36324-36333 (2000).
46. Kitamura, Y.I. et al. FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell Metab. 2, 153-163 (2005).